A unique and biocompatible corneal collagen crosslinking in vivo.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
23 10 2024
Historique:
received: 20 05 2024
accepted: 02 09 2024
medline: 24 10 2024
pubmed: 24 10 2024
entrez: 23 10 2024
Statut: epublish

Résumé

Corneal crosslinking (CXL) is a widely applied technique to halt the progression of ectatic diseases through increasing the thickness and mechanical stiffness of the cornea. This study investigated the biocompatibility and efficiency of a novel CXL procedure using ruthenium and blue light in rat corneas and evaluated parameters important for clinical application. To perform the CXL procedure, the corneal epithelium of rats was removed under anaesthesia, followed by the application of a solution containing ruthenium and sodium persulfate (SPS). The corneas were then exposed to blue light at 430 nm at 3 mW/cm

Identifiants

pubmed: 39443505
doi: 10.1038/s41598-024-71871-9
pii: 10.1038/s41598-024-71871-9
doi:

Substances chimiques

Collagen 9007-34-5
Cross-Linking Reagents 0
Biocompatible Materials 0
Ruthenium 7UI0TKC3U5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

25042

Subventions

Organisme : Türkiye Bilimsel ve Teknolojik Araştırma Kurumu
ID : 219S349

Informations de copyright

© 2024. The Author(s).

Références

Kaur, S. et al. Molecular nature of ocular surface barrier function, diseases that affect it, and its relevance for ocular drug delivery. Ocul. Surf. 30, 3–13 (2023).
pubmed: 37543173 pmcid: 10837323 doi: 10.1016/j.jtos.2023.08.001
Ramier, A. et al. In vivo measurement of shear modulus of the human cornea using optical coherence elastography. Sci. Rep. UK 10(1), 17366 (2020).
doi: 10.1038/s41598-020-74383-4
MacAdam, A. J. et al. Low energy blue pulsed light-activated injectable materials for restoring thinning corneas, advanced functional materials (2023).
Sharif, R., Hjortdal, J., Sejersen, H., Frank, G. & Karamichos, D. Human model reveals the effects of collagen cross-linking on keratoconus pathogenesis. Sci. Rep. UK 7, 12517 (2017).
doi: 10.1038/s41598-017-12598-8
Batista, A., Breunig, H. G., Hager, T., Seitz, B. & Konig, K. Early evaluation of corneal collagen crosslinking in ex-vivo human corneas using two-photon imaging. Sci. Rep. 9(1), 10241 (2019).
pubmed: 31308406 pmcid: 6629644 doi: 10.1038/s41598-019-46572-3
Tian, C. Y., Peng, X. J., Fan, Z. J., Zhang, X. & Zhou, F. H. Corneal collagen cross-linking in keratoconus: A systematic review and meta-analysis. Sci. Rep. UK 4, 5652 (2014).
doi: 10.1038/srep05652
Subasinghe, S. K., Ogbuehi, K. C. & Dias, G. J. Current perspectives on corneal collagen crosslinking (CXL). Graefes Arch. Clin. Exp. Ophthalmol. 256(8), 1363–1384 (2018).
pubmed: 29623463 doi: 10.1007/s00417-018-3966-0
Chen, X. J., Stojanovic, A., Eidet, J. R. & Utheim, T. P. Corneal collagen cross-linking (CXL) in thin corneas. Eye Vis. 2, 15 (2015).
doi: 10.1186/s40662-015-0025-3
Wollensak, G., Spoerl, E., Wilsch, M. & Seiler, T. Endothelial cell damage after riboflavin-ultraviolet-A treatment in the rabbit. J. Cataract Refract. Surg. 29(9), 1786–1790 (2003).
pubmed: 14522302 doi: 10.1016/S0886-3350(03)00343-2
Basak, S., Basak, S. K. & Gupta, R. Acute focal corneal endothelial burn: A unique early and rare complication of corneal cross-linking in keratoconus. J. Cornea Ocul. Surf. 1(1), 61–63 (2023).
doi: 10.4103/JCOS.JCOS_13_22
Donovan, C. et al. Genipin increases extracellular matrix synthesis preventing corneal perforation. Ocul. Surf. 28, 115–123 (2023).
pubmed: 36871831 pmcid: 10440284 doi: 10.1016/j.jtos.2023.02.003
Raiskup, F., Hoyer, A. & Spoerl, E. Permanent corneal haze after riboflavin-UVA-induced cross-linking in keratoconus. J. Refract. Surg. 25(9), S824–S828 (2009).
pubmed: 19772259
Wollensak, G., Spoerl, E., Reber, F. & Seiler, T. Keratocyte cytotoxicity of riboflavin/UVA-treatment. Eye 18(7), 718–722 (2004).
pubmed: 14739922 doi: 10.1038/sj.eye.6700751
Sharma, A. et al. Persistent corneal edema after collagen cross-linking for keratoconus. Am. J. Ophthalmol. 154(6), 922-926 e1 (2012).
pubmed: 22959362 doi: 10.1016/j.ajo.2012.06.005
Muller, P. L. et al. Histological corneal alterations in keratoconus after crosslinking-expansion of findings. Cornea 39(3), 333–341 (2020).
pubmed: 31513045 doi: 10.1097/ICO.0000000000002144
Rubinfeld, R. S., Caruso, C. & Ostacolo, C. Corneal cross-linking: The science beyond the myths and misconceptions. Cornea 38(6), 780–790 (2019).
pubmed: 30882538 doi: 10.1097/ICO.0000000000001912
Elbaz, U. et al. Accelerated (9 mW/cm2) corneal collagen crosslinking for keratoconus—A 1-year follow-up. Cornea 34(1), e1-2 (2015).
pubmed: 25379872 doi: 10.1097/ICO.0000000000000299
Aldairi, W. et al. Accelerated versus conventional corneal collagen crosslinking: Short-term clinical outcomes in stabilizing keratoconus. Saudi J. Ophthalmol. 36(1), 47–52 (2022).
pubmed: 35971481 pmcid: 9375457 doi: 10.4103/sjopt.sjopt_49_22
Peyman, A., Nouralishahi, A., Hafezi, F., Kling, S. & Peyman, M. Stromal demarcation line in pulsed versus continuous light accelerated corneal cross-linking for keratoconus. J. Refract. Surg. 32(3), 206–208 (2016).
pubmed: 27027629 doi: 10.3928/1081597X-20160204-03
Kobashi, H. & Tsubota, K. Accelerated versus standard corneal cross-linking for progressive keratoconus: A meta-analysis of randomized controlled trials. Cornea 39(2), 172–180 (2020).
pubmed: 31369463 doi: 10.1097/ICO.0000000000002092
Turhan, S. A., Yargi, B. & Toker, E. Efficacy of conventional versus accelerated corneal cross-linking in pediatric keratoconus: Two-year outcomes. J. Refract. Surg. 36(4), 265–269 (2020).
pubmed: 32267958 doi: 10.3928/1081597X-20200302-01
Seiler, T. G. et al. Oxygen kinetics during corneal cross-linking with and without supplementary oxygen. Am. J. Ophthalmol. 223, 368–376 (2021).
pubmed: 33227242 doi: 10.1016/j.ajo.2020.11.001
Mazzotta, C., Traversi, C., Caragiuli, S. & Rechichi, M. Pulsed vs continuous light accelerated corneal collagen crosslinking: In vivo qualitative investigation by confocal microscopy and corneal OCT. Eye (Lond) 28(10), 1179–1183 (2014).
pubmed: 25060847 doi: 10.1038/eye.2014.163
Ting, D. S. J. et al. Effectiveness and safety of accelerated (9 mW/cm2) corneal collagen cross-linking for progressive keratoconus: A 24-month follow-up. Eye 33(5), 812–818 (2019).
pubmed: 30610230 pmcid: 6707229 doi: 10.1038/s41433-018-0323-9
Chow, V. W. S., Chan, T. C. Y., Yu, M., Wong, V. W. Y. & Jhanji, V. One-year outcomes of conventional and accelerated collagen crosslinking in progressive keratoconus. Sci. Rep. 5, 14425 (2015).
pubmed: 26404661 pmcid: 4585888 doi: 10.1038/srep14425
Gulzar, A. et al. Ruthenium-induced corneal collagen crosslinking under visible light. Acta Biomater. 147, 198–208 (2022).
pubmed: 35643198 doi: 10.1016/j.actbio.2022.05.040
Sauvage, J. P. et al. Ruthenium(II) and Osmium(II) bis(terpyridine) complexes in covalently-linked multicomponent systems—Synthesis electrochemical-behavior, absorption-spectra, and photochemical and photophysical properties. Chem. Rev. 94(4), 993–1019 (1994).
doi: 10.1021/cr00028a006
Bjork, J. W., Johnson, S. L. & Tranquillo, R. T. Ruthenium-catalyzed photo cross-linking of fibrin-based engineered tissue. Biomaterials 32(10), 2479–2488 (2011).
pubmed: 21196047 doi: 10.1016/j.biomaterials.2010.12.010
Lewandowska-Andralojc, A. & Polyansky, D. E. Mechanism of the quenching of the tris(bipyridine)ruthenium(ii) emission by persulfate: Implications for photoinduced oxidation reactions. J. Phys. Chem. A 117(40), 10311–10319 (2013).
pubmed: 24040757 doi: 10.1021/jp407573d
Inomata, T., Mashaghi, A., Hong, J. X., Nakao, T. & Dana, R. Scaling and maintenance of corneal thickness during aging. PLoS One 12(10), e185694 (2017).
Kim, D. W. et al. PEP-1-FK506BP inhibits alkali burn-induced corneal inflammation on the rat model of corneal alkali injury. BMB Rep. 48(11), 618–623 (2015).
pubmed: 25817214 pmcid: 4911203 doi: 10.5483/BMBRep.2015.48.11.041
Song, Y. H. et al. Application of collagen I and IV in bioengineering transparent ocular tissues. Front. Surg. 8, 639500 (2021).
pubmed: 34513910 pmcid: 8427501 doi: 10.3389/fsurg.2021.639500
Schulz, D., Iliev, M. E., Frueh, B. E. & Goldblum, D. In vivo pachymetry in normal eyes of rats, mice and rabbits with the optical low coherence reflectometer. Vis. Res. 43(6), 723–728 (2003).
pubmed: 12604109 doi: 10.1016/S0042-6989(03)00005-1
Hammer, A. et al. Establishing corneal cross-linking with riboflavin and UV-A in the mouse cornea in vivo: Biomechanical analysis. Investig. Ophthalmol. Vis. Sci. 56(11), 6581–6590 (2015).
doi: 10.1167/iovs.15-17426
Kling, S., Hammer, A., Conti, A. & Hafezi, F. Corneal cross-linking with riboflavin and UV-A in the mouse cornea in vivo: Morphological, biochemical, and physiological analysis. Transl. Vis. Sci. Technol. 6(1), 7 (2017).
pubmed: 28149672 pmcid: 5283086 doi: 10.1167/tvst.6.1.7
Mazzotta, C., Jacob, S., Agarwal, A. & Kumar, D. A. In vivo confocal microscopy after contact lens-assisted corneal collagen cross-linking for thin keratoconic corneas. J. Refract. Surg. 32(5), 326–331 (2016).
pubmed: 27163618 doi: 10.3928/1081597X-20160225-04
Tillmann, A. et al. Acute corneal melt and perforation—A possible complication after riboflavin/UV-A crosslinking (CXL) in keratoconus. Am. J. Ophthalmol. Case Rep. 28, 101705 (2022).
pubmed: 36187442 pmcid: 9519437 doi: 10.1016/j.ajoc.2022.101705
Hovakimyan, M. et al. Short-term corneal response to cross-linking in rabbit eyes assessed by in vivo confocal laser scanning microscopy and histology. Cornea 30(2), 196–203 (2011).
pubmed: 20861724 doi: 10.1097/ICO.0b013e3181e16d93
Kizilel, S., Şahin, A., Taş, A. Y., Nazeer, M. A., Gulzar, A. & Yildiz, E. A method and a pharmaceutical composition for visible light-induced corneal crosslinking with ruthenium compounds for the treatment of eye disorders. In WO/2024/054165. https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2024054165&_cid=P21-LWEMZJ-87892-1 (2024).
Fancy, D. A. & Kodadek, T. Chemistry for the analysis of protein-protein interactions: Rapid and efficient cross-linking triggered by long wavelength light (vol 96, pg 6020, 1999). Proc. Natl. Acad. Sci. USA 97(3), 1317–1317 (2000).
Rapp, T. L. & Dmochowski, I. J. Ruthenium-cross-linked hydrogels for rapid, visible-light protein release Teresa. Method Enzymol. 624, 151–166 (2019).
doi: 10.1016/bs.mie.2019.04.017
Hollhumer, R., Watson, S. & Beckingsale, P. Persistent epithelial defects and corneal opacity after collagen cross-linking with substitution of dextran (T-500) with dextran sulfate in compounded topical riboflavin. Cornea 36(3), 382–385 (2017).
pubmed: 28129292 doi: 10.1097/ICO.0000000000001134
Bourne, W. M. Biology of the corneal endothelium in health and disease. Eye 17(8), 912–918 (2003).
pubmed: 14631396 doi: 10.1038/sj.eye.6700559
Jiang, G. J., You, X. G. & Fan, T. J. Ultraviolet B irradiation induces senescence of human corneal endothelial cells in vitro by DNA damage response and oxidative stress. J. Photochem. Photobiol. B 235, 112568 (2022).
pubmed: 36137302 doi: 10.1016/j.jphotobiol.2022.112568
Han, M. et al. Photovoltaic neurointerface based on aluminum antimonide nanocrystals. Commun. Mater. 2(1), 19 (2021).
doi: 10.1038/s43246-021-00123-4
Mazzotta, C. et al. Corneal healing after riboflavin ultraviolet-A collagen cross-linking determined by confocal laser scanning microscopy in vivo: Early and late modifications. Am. J. Ophthalmol. 146(4), 527–533 (2008).
pubmed: 18672225 doi: 10.1016/j.ajo.2008.05.042
Messmer, E. M. et al. Morphological and immunohistochemical changes after corneal cross-linking. Cornea 32(2), 111–117 (2013).
pubmed: 22580432 doi: 10.1097/ICO.0b013e31824d701b
Wollensak, G., Spoerl, E., Wilsch, M. & Seiler, T. Keratocyte apoptosis after corneal collagen cross-linking using riboflavin/UVA treatment. Cornea 23(1), 43–49 (2004).
pubmed: 14701957 doi: 10.1097/00003226-200401000-00008
Bilgihan, K. et al. Keratocyte apoptosis and corneal antioxidant enzyme activities after refractive corneal surgery. Eye 16(1), 63–68 (2002).
pubmed: 11913891 doi: 10.1038/sj.eye.6700065
West-Mays, J. A. & Dwivedi, D. J. The keratocyte: Corneal stromal cell with variable repair phenotypes. Int. J. Biochem. Cell B 38(10), 1625–1631 (2006).
doi: 10.1016/j.biocel.2006.03.010
Zhu, Y. R. et al. Corneal collagen cross-linking with riboflavin and UVA regulates hemangiogenesis and lymphangiogenesis in rats. Investig. Ophthalmol. Vis. Sci. 59(8), 3702–3712 (2018).
doi: 10.1167/iovs.17-23036
Espana, E. M. & Birk, D. E. Composition, structure and function of the corneal stroma. Exp. Eye Res. 198, 108137 (2020).
pubmed: 32663498 pmcid: 7508887 doi: 10.1016/j.exer.2020.108137
Greenstein, S. A., Fry, K. L., Bhatt, J. & Hersh, P. S. Natural history of corneal haze after collagen crosslinking for keratoconus and corneal ectasia: Scheimpflug and biomicroscopic analysis. J. Cataract Refract. Surg. 36(12), 2105–2114 (2010).
pubmed: 21111314 doi: 10.1016/j.jcrs.2010.06.067
Dhaliwal, J. S. & Kaufman, S. C. Corneal collagen cross-linking: A confocal, electron, and light microscopy study of eye bank corneas. Cornea 28(1), 62–67 (2009).
pubmed: 19092408 doi: 10.1097/ICO.0b013e31818225c3
Xia, Y., Liu, B. C., Fan, Z. J. & Peng, X. J. Corneal collagen fibril changes after ultraviolet A/riboflavin corneal crosslinking. Cornea 33(1), 56–59 (2014).
pubmed: 24240489 doi: 10.1097/ICO.0000000000000017
Wollensak, G. & Spoerl, E. Collagen crosslinking of human and porcine sclera. J. Cataract Refract. Surg. 30(3), 689–695 (2004).
pubmed: 15050269 doi: 10.1016/j.jcrs.2003.11.032

Auteurs

Ayesha Gulzar (A)

Biomedical Sciences and Engineering, Koç University, 34450, Istanbul, Turkey.

Humeyra N Kaleli (HN)

Koç University Research Center for Translational Medicine (KUTTAM), Koç University, 34450, Istanbul, Turkey.

Gülsüm D Köseoğlu (GD)

Koç University Research Center for Translational Medicine (KUTTAM), Koç University, 34450, Istanbul, Turkey.

Murat Hasanreisoğlu (M)

Koç University Research Center for Translational Medicine (KUTTAM), Koç University, 34450, Istanbul, Turkey.
Department of Ophthalmology, Koç University School of Medicine, 34010, Istanbul, Turkey.

Ayşe Yıldız (A)

Department of Ophthalmology, Koç University School of Medicine, 34010, Istanbul, Turkey.

Afsun Şahin (A)

Koç University Research Center for Translational Medicine (KUTTAM), Koç University, 34450, Istanbul, Turkey. afsahin@ku.edu.tr.
Department of Ophthalmology, Koç University School of Medicine, 34010, Istanbul, Turkey. afsahin@ku.edu.tr.

Seda Kizilel (S)

Biomedical Sciences and Engineering, Koç University, 34450, Istanbul, Turkey. skizilel@ku.edu.tr.
Koç University Research Center for Translational Medicine (KUTTAM), Koç University, 34450, Istanbul, Turkey. skizilel@ku.edu.tr.
Chemical and Biological Engineering, Koç University, 34450, Istanbul, Turkey. skizilel@ku.edu.tr.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH